Skip to main content
. Author manuscript; available in PMC: 2014 Feb 27.
Published in final edited form as: Lancet Oncol. 2012 Sep 4;13(10):1011–1019. doi: 10.1016/S1470-2045(12)70344-3

Table 1.

Patient demographics and baseline disease characteristics

Patients (n=149)
Age (years) 52 (21–86)

Men 73 (49%)

Women 76 (51%)

Ethnic origin
 White 95 (64%)
 Asian 41 (28%)
 Other 13 (9%)

Smoking status
 Never 106 (71%)
 Former 42 (28%)
 Present 1 (<1%)

Histological findings
 Adenocarcinoma 144 (97%)
 Large-cell carcinoma 1 (<1%)
 Squamous-cell carcinoma 2 (1%)
 Other 2 (1%)

ECOG PS score
 0 56 (38%)
 1 75 (50%)
 ≥2 18 (12%)

Number of previous advanced or metastatic treatment regimens
 0 24 (16%)
 1 47 (32%)
 2 31 (21%)
 3 19 (13%)
 ≥4 28 (19%)

Data are median (range) or number (%). Some % do not sum to 100 because of rounding. ECOG PS=Eastern Cooperative Oncology Group performance status.